BN Business News
Add your company to Business Communicator →

Energy & environment · 21/09/2006Updated: 10/17/2026 · 1 min read

SK Bio-Pharmaceutical to Release R&D Center Facility in NJ After Environmental Review

Summary

The U.S. Environmental Protection Agency has made available an environmental assessment and finding of no significant impact for SK Bio-Pharmaceutical's license amendment, allowing for the unrestricted release of its R&D center in Fairfield, NJ, following the termination of its license.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Explore insights

Business insights →